Streetbeat News

Stock Prices

LIDR

AEye, Inc. (LIDR) shares surged following the announcement of a partnership with LITEON Technology Corporation, signaling a positive development for the company.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:13 pm

BRLT

Brilliant Earth forecasts a year-over-year decline in Q2 net sales, expecting them to fall in the low to mid-single digit percentage range.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:11 pm

PDSB

PDS Biotech announced that its VERSATILE-002 Phase 2 clinical trial met its primary study endpoints, indicating positive outcomes for the company's development pipeline.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:09 pm

GEOS

Geospace Technologies (GEOS) has announced a stock repurchase program, authorizing the buyback of up to $5 million of its outstanding common stock. The repurchases can be made through open market transactions, block trades, privately negotiated transactions, or under a Rule 10b5-1 trading plan.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:07 pm

GEOS

Geospace Technologies reported a significant decrease in both earnings per share and sales for Q2, with EPS dropping to $(0.32) from $0.35 YoY and sales falling to $24.27M from $31.37M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:05 pm

SKIN

BeautyHealth projects its Q2 2024 net sales to be between $96M and $102M, which is below the estimated $107.183M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:04 pm

GEOS

Geospace Technologies (NASDAQ:GEOS) reported a decrease in Q2 earnings to $0.32 per share from $0.35 YoY, with sales falling to $24.27M from $31.37M YoY, indicating a decline in both earnings and revenue.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:04 pm

DOGZ

Dogness (International) Corporation (NASDAQ:DOGZ) announced a private placement of 2 million shares at $2.50 per share, raising $5 million in gross proceeds. The shares are sold to non-U.S. purchasers under Regulation S, exempt from registration under the Securities Act of 1933. The closing of the private placement is subject to customary conditions.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:03 pm

CMAX

CareMax reported Q1 2024 earnings of $11.49 per share, surpassing the $(8.70) estimate, with sales of $232.200M beating the $197.239M estimate, marking a 34.23% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:00 pm

ZOM

Zomedica's stock price declined following the announcement of a year-over-year decrease in Q1 GAAP EPS results and the issuance of Q1 sales results that fell below expectations.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:00 pm